|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/0051 | (2013.01) |
| A61L 27/38 | (2006.01) | ||
| A61K 35/12 | (2015.01) | ||
| A61K 38/179 | (2013.01) | ||
| A61K 9/00 | (2006.01) | ||
| C12N 5/0012 | (2013.01) | ||
| C12N2510/02 | (2013.01) | ||
| A61F 9/00 | (2013.01) | ||
| A61P 1/00 | (2018.01) | ||
| A61P 1/02 | (2018.01) | ||
| A61P 1/16 | (2018.01) | ||
| A61P 11/00 | (2018.01) | ||
| A61P 13/08 | (2018.01) | ||
| A61P 13/12 | (2018.01) | ||
| A61P 17/00 | (2018.01) | ||
| A61P 25/00 | (2018.01) | ||
| A61P 25/28 | (2018.01) | ||
| A61P 27/02 | (2018.01) | ||
| A61P 27/06 | (2018.01) | ||
| A61P 27/12 | (2018.01) | ||
| A61P 29/00 | (2018.01) | ||
| A61P 3/00 | (2018.01) | ||
| A61P 31/04 | (2018.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61P 37/02 | (2018.01) | ||
| A61P 43/00 | (2018.01) | ||
| A61P 5/00 | (2018.01) | ||
| A61P 7/00 | (2018.01) | ||
| A61P 9/00 | (2018.01) | ||
| A61P 9/10 | (2018.01) |
| (11) | Number of the document | 3043836 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14776945.9 |
| Date of filing the European patent application | 2014-09-10 | |
| (97) | Date of publication of the European application | 2016-07-20 |
| (45) | Date of publication and mention of the grant of the patent | 2023-05-10 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2014/055028 |
| Date | 2014-09-10 |
| (87) | Number | WO 2015/038669 |
| Date | 2015-03-19 |
| (30) | Number | Date | Country code |
| 201361876638 P | 2013-09-11 | US |
| (72) |
KAUPER, Konrad A. , US
MILLS, John Fraser , US
BILLINGS, Megan , US
RIVERA, Michael R. , US
LELIS, Alline Monteiro Alcantara , US
|
| (73) |
Neurotech USA, Inc. ,
900 Highland Corporate Drive
Building No. 1
Suite No. 101, Cumberland, RI 02864,
US
|
| (54) | ENCAPSULATED CELL THERAPY CARTRIDGE |
| ENCAPSULATED CELL THERAPY CARTRIDGE |